DuLac Farmaceutici Plans Broader U.S. Expansion Following Amazon Growth
Italian wellness company DuLac Farmaceutici, leveraging its pharmaceutical heritage and Amazon success, announces plans to expand U.S. distribution into retail and wellness channels.
DuLac Farmaceutici, the Italian wellness company known for its recovery-focused dermocosmetic products, today announced plans to expand its presence across the United States following continued growth through its Amazon U.S. storefront. The company, built on more than 30 years of pharmaceutical industry experience, aims to broaden awareness across additional retail, e-commerce, wellness, and recovery-focused distribution channels in the coming months.
DuLac's expansion strategy reflects increasing consumer demand for wellness and recovery products developed with pharmaceutical-grade precision, clean-label formulations, and ingredient traceability. The company's portfolio includes recovery-focused dermocosmetic products, wellness solutions, and circulation-support formulations designed for active lifestyles and everyday comfort. Key products include its Arnica Gel 98% collection, Arnica Gel 98% Formula Complex recovery products, and vascular and microcirculation wellness solutions such as Diosmin 500 and Dinaven.
“At DuLac, our mission has always been to develop innovative and effective wellness solutions rooted in both science and nature,” said Gabriele Bollani, Founder and CEO of DuLac Farmaceutici. “We are excited to continue expanding our presence in the United States and introduce more consumers to products developed through decades of Italian pharmaceutical expertise, advanced research, and high-quality manufacturing standards.”
For its Arnica Gel 98% formulations, DuLac utilizes a vertically integrated “seed-to-shelf” production model designed to support phytocomplex consistency, traceability, and quality control across cultivation, extraction, formulation, and manufacturing. The company also employs advanced technologies such as supercritical CO₂ extraction and controlled-environment cultivation systems to preserve botanical integrity.
DuLac recently partnered with a state-of-the-art 2,500-square-meter research and manufacturing hub in Italy that combines AI-assisted formulation technology with pharmaceutical-grade production standards. The facility operates under GMP, ISO 22716, and ISO 9001 quality frameworks and supports the company's growing international expansion efforts.
“Our goal is not simply to sell wellness products, but to elevate standards across the category,” added Bollani. “By combining pharmaceutical expertise, modern innovation, and carefully selected natural ingredients, we are building solutions designed around real consumer wellness needs.”
The company's Italian pharmaceutical heritage, vertically integrated production, and clean-label philosophy differentiate it in the U.S. market. As DuLac expands beyond Amazon, it aims to target additional retail and wellness channels, leveraging its AI-assisted manufacturing and Made in Italy quality standards.